[
  {
    "question": "How is HIV diagnosed?",
    "answer": "HIV (Human Immunodeficiency Virus) diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Here's a step-by-step overview of the diagnostic process:\n\n1. **Medical History and Risk Assessment**: A healthcare provider will ask about your medical history, including any symptoms, previous illnesses, and risk factors for HIV, such as:\n\t* Unprotected sex with multiple partners\n\t* Injecting drugs or sharing needles\n\t* Blood transfusions or organ transplants before 1985\n\t* Having a sexually transmitted infection (STI)\n\t* Being born to an HIV-positive mother\n2. **Physical Examination**: A physical examination may be performed to look for signs of immune system suppression, such as:\n\t* Weight loss\n\t* Fever\n\t* Swollen lymph nodes\n\t* Skin rashes or lesions\n3. **Laboratory Tests**: The following laboratory tests are used to diagnose HIV:\n\t* **Rapid Tests**: These are quick tests that can provide results in 20-30 minutes. They detect the presence of HIV antibodies in blood or oral fluid.\n\t* **Enzyme-Linked Immunosorbent Assay (ELISA)**: This test detects HIV antibodies in blood and is often used as a preliminary test.\n\t* **Western Blot**: This test is used to confirm the diagnosis of HIV infection and detect the presence of specific HIV proteins.\n\t* **Polymerase Chain Reaction (PCR)**: This test detects the genetic material of the virus (RNA or DNA) and is often used to diagnose HIV in infants born to HIV-positive mothers.\n\t* **Viral Load Test**: This test measures the amount of HIV in the blood and is used to monitor the effectiveness of antiretroviral therapy (ART).\n4. **Window Period**: It's essential to note that there is a \"window period\" between the time of HIV infection and the time when the test can detect the virus. This period can range from 2-12 weeks, depending on the test used. During this time, a person may not test positive for HIV, even if they are infected.\n5. **Confirmatory Testing**: If a preliminary test is positive, a confirmatory test is performed to confirm the diagnosis. This may involve repeating the initial test or using a different test, such as a Western Blot.\n6. **CD4 Cell Count and Viral Load Testing**: After diagnosis, these tests are used to monitor the progression of the disease and the effectiveness of treatment.\n\nIt's crucial to note that HIV testing should be done with informed consent, and individuals should be counseled about the risks and benefits of testing, as well as the importance of confidentiality and anonymity. If you think you may have been exposed to HIV, it's essential to get tested as soon as possible and seek medical attention if you test positive.",
    "true_answer": "HIV is diagnosed through HIV testing. There are three types of tests used to diagnose HIV infection: antibody tests, antigen/antibody tests, and nucleic acid tests (NATs). How soon each test can detect HIV infection differs, because each test has a different window period. The window period is the time between when a person may have been exposed to HIV and when a test can accurately detect HIV infection. Window periods for different HIV tests are the followings: Antibody tests can usually detect HIV 23 to 90 days after exposure. Most rapid tests and self-tests are antibody tests. A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure. An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A NAT can usually detect HIV 10 to 33 days after exposure. When an HIV test is positive, a follow-up test will be conducted for confirmation. Sometimes people will need to visit a health care provider to take a follow-up test using another blood sample. Other times, the follow-up test may be performed in a lab using the original blood sample to ensure that the first positive result wasn\u2019t a false positive"
  },
  {
    "question": "What are the different stages of HIV?",
    "answer": "HIV (Human Immunodeficiency Virus) infection progresses through several stages, which can vary in duration and severity from person to person. The stages of HIV are:\n\n**Stage 1: Acute HIV Infection (0-6 months)**\n\n* This is the initial stage of HIV infection, during which the virus rapidly replicates and spreads throughout the body.\n* Many people experience flu-like symptoms, such as fever, fatigue, and rash, which can last for a few weeks.\n* The viral load is very high during this stage, making it highly contagious.\n\n**Stage 2: Clinical Latency (6 months to 10-15 years)**\n\n* During this stage, the virus is still active, but it replicates at a slower rate.\n* The person may not exhibit any symptoms, and the viral load may be lower.\n* The immune system is still able to fight off infections, but it is slowly being damaged by the virus.\n* This stage can last for many years, and some people may not even know they are infected.\n\n**Stage 3: Symptomatic HIV Infection (10-15 years or more)**\n\n* As the virus continues to damage the immune system, the person may start to experience symptoms, such as:\n\t+ Weight loss\n\t+ Fatigue\n\t+ Swollen lymph nodes\n\t+ Diarrhea\n\t+ Skin rashes\n\t+ Yeast infections\n* The viral load increases, and the person becomes more susceptible to opportunistic infections (OIs).\n\n**Stage 4: AIDS (Acquired Immunodeficiency Syndrome)**\n\n* This is the most advanced stage of HIV infection, during which the immune system is severely damaged.\n* The person is highly susceptible to OIs, such as:\n\t+ Pneumocystis pneumonia (PCP)\n\t+ Toxoplasmosis\n\t+ Kaposi's sarcoma\n\t+ Lymphoma\n* AIDS is diagnosed when the CD4 cell count (a type of immune cell) falls below 200 cells per cubic millimeter of blood.\n\n**Undetectable Viral Load**\n\n* With effective antiretroviral therapy (ART), it is possible to suppress the viral load to undetectable levels.\n* This means that the virus is still present, but it is not actively replicating, and the person is much less likely to transmit the virus to others.\n* An undetectable viral load is not a cure, but it is a significant achievement in managing the infection and preventing disease progression.\n\nIt's essential to note that with proper treatment and care, many people with HIV can live long and healthy lives, and the disease can be managed effectively. Early diagnosis and treatment are critical in preventing disease progression and reducing the risk of transmission to others.",
    "true_answer": "The different stages of HIV are either defined as three: (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS); or four: (1) acute HIV infection, (2) asymptomatic stage, (3) symptomatic HIV, and (4) Late-stage HIV or AIDS."
  },
  {
    "question": "How is HIV transmitted?",
    "answer": "HIV (Human Immunodeficiency Virus) is transmitted through certain bodily fluids from a person who is infected with the virus. The main modes of transmission are:\n\n1. **Sexual contact**: HIV can be transmitted through vaginal, anal, or oral sex with an infected person. The risk of transmission is higher if the infected person has a high viral load or if the other person has open sores or wounds.\n2. **Blood-to-blood contact**: HIV can be transmitted through:\n\t* Sharing needles or syringes with an infected person.\n\t* Receiving a blood transfusion from an infected donor (although this is rare in countries with strict blood screening).\n\t* Organ transplantation from an infected donor.\n3. **Mother-to-child transmission**: HIV can be transmitted from an infected mother to her child during:\n\t* Pregnancy (in utero).\n\t* Childbirth (through exposure to blood and vaginal fluids).\n\t* Breastfeeding (if the mother is not taking antiretroviral therapy).\n4. **Occupational exposure**: Healthcare workers may be at risk of transmission through:\n\t* Needlestick injuries.\n\t* Exposure to infected blood or bodily fluids through cuts or abrasions.\n\nIt's essential to note that HIV is **not** transmitted through:\n\n* Casual contact (shaking hands, hugging, sharing food or drinks).\n* Air or water.\n* Insect bites.\n* Saliva, sweat, or tears (unless these fluids are mixed with blood).\n\nTo prevent HIV transmission, it's crucial to:\n\n* Practice safe sex (use condoms, dental dams, or other barrier methods).\n* Use sterile needles and syringes.\n* Get tested for HIV regularly.\n* Take antiretroviral therapy (ART) if diagnosed with HIV to suppress the virus.\n* Follow proper infection control procedures in healthcare settings.\n\nIf you have any concerns or questions, feel free to ask!",
    "true_answer": "HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It can also spread from a mother to her baby."
  },
  {
    "question": "What comorbidities are common among people living with HIV?",
    "answer": "People living with HIV (PLWH) are at increased risk of developing various comorbidities due to the immune suppression, chronic inflammation, and antiretroviral therapy (ART) side effects associated with the disease. Some common comorbidities among PLWH include:\n\n1. **Cardiovascular diseases**: HIV infection increases the risk of cardiovascular diseases, such as coronary artery disease, heart failure, and stroke, due to chronic inflammation, dyslipidemia, and ART-related side effects.\n2. **Mental health disorders**: Depression, anxiety, and substance use disorders are common among PLWH, often related to the psychological burden of living with a chronic illness, stigma, and social isolation.\n3. **Chronic kidney disease**: HIV-related kidney disease, also known as HIV-associated nephropathy (HIVAN), is a significant comorbidity, particularly among African Americans.\n4. **Hepatitis B and C coinfections**: PLWH are at increased risk of coinfection with hepatitis B and C viruses, which can lead to liver disease, cirrhosis, and liver cancer.\n5. **Tuberculosis (TB)**: TB is a leading cause of morbidity and mortality among PLWH, particularly in resource-limited settings.\n6. **Cancer**: PLWH are at increased risk of various cancers, including:\n\t* Kaposi's sarcoma\n\t* Non-Hodgkin lymphoma\n\t* Hodgkin lymphoma\n\t* Anal cancer\n\t* Liver cancer\n\t* Lung cancer\n7. **Osteoporosis**: HIV infection and ART can increase the risk of osteoporosis, particularly among older adults and those with a history of substance abuse or malnutrition.\n8. **Diabetes mellitus**: PLWH are at increased risk of developing insulin resistance and type 2 diabetes, particularly those taking certain ART regimens.\n9. **Lipodystrophy**: ART-related lipodystrophy, characterized by abnormal fat distribution, can increase the risk of cardiovascular disease and metabolic disorders.\n10. **Neurological disorders**: HIV-associated neurocognitive disorders (HAND), including dementia, are common among PLWH, particularly those with advanced disease or poor ART adherence.\n11. **Gastrointestinal disorders**: PLWH may experience gastrointestinal symptoms, such as diarrhea, abdominal pain, and weight loss, due to opportunistic infections, ART side effects, or other comorbidities.\n12. **Respiratory diseases**: PLWH are at increased risk of respiratory diseases, including chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer.\n13. **Malnutrition and wasting**: Malnutrition and wasting are common among PLWH, particularly in resource-limited settings, and can increase the risk of opportunistic infections and mortality.\n14. **Sleep disorders**: PLWH may experience sleep disorders, such as insomnia, sleep apnea, and restless leg syndrome, due to the psychological burden of living with HIV, ART side effects, or other comorbidities.\n15. **Dental and periodontal diseases**: PLWH are at increased risk of dental and periodontal diseases, including tooth loss, due to immune suppression, poor oral health, and ART-related side effects.\n\nThese comorbidities can significantly impact the quality of life, morbidity, and mortality of PLWH, emphasizing the importance of comprehensive care, including regular health check-ups, screening for comorbidities, and management of related conditions.",
    "true_answer": "The most common comorbidities amongst patients with HIV include: diabetes mellitus, cardiovascular disease (CVD, e.g. hypertension), respiratory diseases (e.g. chronic obstructive pulmonary diseases and pneumonia), and hepatic diseases (hepatitis B and C). Liver disease, renal disease, substance dependence and abuse, sexually transmitted infections (herpes simplex, syphilis, gonorrhoea and Mycoplasma genitalium) and psychiatric disorders (including depression, anxiety, schizophrenia and cognitive impairment) are also greater among HIV-positive individuals."
  },
  {
    "question": "How can HIV be prevented?",
    "answer": "HIV (Human Immunodeficiency Virus) can be prevented through a combination of strategies that reduce the risk of transmission. Here are some effective ways to prevent HIV:\n\n1. **Safe Sex Practices**: Use condoms consistently and correctly during vaginal, anal, and oral sex. This can significantly reduce the risk of HIV transmission.\n2. **Pre-Exposure Prophylaxis (PrEP)**: Take antiretroviral medication daily to prevent HIV infection before exposure. PrEP is recommended for individuals at high risk of HIV infection, such as those with multiple sex partners or those who engage in high-risk behaviors.\n3. **Post-Exposure Prophylaxis (PEP)**: Take antiretroviral medication within 72 hours of potential exposure to HIV to prevent infection.\n4. **HIV Testing and Counseling**: Get tested regularly for HIV and receive counseling on risk reduction and prevention strategies.\n5. **Monogamy and Faithfulness**: Being in a mutually monogamous relationship with an HIV-negative partner can significantly reduce the risk of HIV transmission.\n6. **Avoid Sharing Needles and Syringes**: Sharing needles and syringes can transmit HIV and other blood-borne pathogens. Use sterile needles and syringes, and avoid sharing them with others.\n7. **Screening for Sexually Transmitted Infections (STIs)**: Regularly screen for STIs, such as chlamydia, gonorrhea, and syphilis, which can increase the risk of HIV transmission.\n8. **Vaccination**: Get vaccinated against hepatitis B and human papillomavirus (HPV), which can increase the risk of HIV transmission.\n9. **Harm Reduction Programs**: Participate in harm reduction programs, such as needle exchange programs, which provide sterile needles and syringes to reduce the risk of HIV transmission.\n10. **Education and Awareness**: Educate yourself and others about HIV transmission, prevention, and treatment to reduce stigma and promote safe behaviors.\n11. **Male Circumcision**: Male circumcision has been shown to reduce the risk of HIV transmission in men by up to 60%.\n12. **Antiretroviral Therapy (ART)**: If you are living with HIV, taking ART as prescribed can suppress the virus, reducing the risk of transmission to others.\n\nRemember, HIV prevention is a shared responsibility, and it requires a combination of individual and community-based efforts. By adopting these strategies, you can significantly reduce your risk of HIV transmission and help prevent the spread of the virus.",
    "true_answer": "HIV prevention involves several key strategies. To reduce the risk of getting HIV, it is important to use condoms correctly every time during sex. For individuals who inject drugs, avoiding drug use altogether is recommended, but if drugs are used, only sterile injection equipment and water should be used, and equipment should never be shared with others. Pre-exposure prophylaxis (PrEP) is an option for those at risk of HIV, involving either a daily HIV medicine or an injectable HIV medicine every two months to lower the risk of infection through sex or injection drug use. For those already living with HIV, taking antiretroviral therapy (ART) as prescribed can reduce the amount of HIV in the blood to undetectable levels, preventing transmission to sexual partners. To prevent perinatal transmission, individuals with HIV who take HIV medicine as prescribed throughout pregnancy and childbirth reduce the risk of passing HIV to their baby to less than 1%. Additionally, in cases where one partner has HIV, PrEP can help protect both the individual and their baby while trying to conceive, during pregnancy, or while breastfeeding."
  },
  {
    "question": "How frequently ART must be taken?",
    "answer": "ART, or Antiretroviral Therapy, is a treatment for HIV (Human Immunodeficiency Virus) that involves taking a combination of medications to suppress the virus and prevent it from progressing to AIDS (Acquired Immunodeficiency Syndrome).\n\nThe frequency of taking ART medications varies depending on the specific regimen and the individual's treatment plan. However, most ART regimens require taking medications:\n\n1. **Once a day**: Many ART regimens involve taking one or two pills once a day, with or without food.\n2. **Twice a day**: Some regimens may require taking medications twice a day, usually morning and evening.\n3. **Every 8-12 hours**: A few medications, such as some protease inhibitors, may need to be taken every 8-12 hours.\n\nIt's essential to take ART medications **exactly as prescribed** by your healthcare provider, including:\n\n* Taking the correct dose\n* At the right time\n* With or without food (as directed)\n* Not missing doses or skipping pills\n\nAdhering to the treatment regimen is crucial to:\n\n* Suppress the virus\n* Prevent drug resistance\n* Maintain a healthy immune system\n* Reduce the risk of transmission to others\n\nIf you have any questions or concerns about your ART regimen, be sure to discuss them with your healthcare provider. They can help you understand your treatment plan and provide guidance on how to take your medications correctly.",
    "true_answer": "Antiretroviral therapy (ART) must be taken as a pill every day or as a shot once every month or two months."
  },
  {
    "question": "How can we prevent Perinatal transmission of HIV?",
    "answer": "Preventing perinatal transmission of HIV, also known as mother-to-child transmission (MTCT), is crucial to reduce the risk of HIV infection in newborns. Here are the ways to prevent perinatal transmission of HIV:\n\n1. **HIV Testing and Counseling**: All pregnant women should be tested for HIV as part of routine prenatal care. If a woman is found to be HIV-positive, she should receive counseling on the risk of MTCT and the available interventions to prevent it.\n2. **Antiretroviral Therapy (ART)**: Providing ART to HIV-positive pregnant women can significantly reduce the risk of MTCT. The goal is to suppress the viral load to undetectable levels, making it less likely for the virus to be transmitted to the baby.\n3. **Combination Antiretroviral Prophylaxis**: Administering a combination of antiretroviral drugs to the mother during pregnancy, labor, and delivery, and to the newborn after birth, can further reduce the risk of MTCT.\n4. **Elective Cesarean Delivery**: For women with high viral loads or unknown viral loads, elective cesarean delivery before the onset of labor and before the rupture of membranes can reduce the risk of MTCT.\n5. **Avoidance of Breastfeeding**: HIV-positive mothers should be advised against breastfeeding, as HIV can be transmitted through breast milk. Instead, they should be encouraged to use formula feeding or expressed breast milk from an HIV-negative donor.\n6. **Post-Exposure Prophylaxis (PEP)**: For newborns born to HIV-positive mothers, PEP with antiretroviral drugs can be administered within the first 72 hours of life to reduce the risk of MTCT.\n7. **Pre-Conception Care**: For women with HIV who are planning to become pregnant, pre-conception care can help reduce the risk of MTCT. This includes optimizing ART, achieving viral suppression, and receiving counseling on safe conception practices.\n8. **Male Involvement**: Encouraging male partners to get tested for HIV and involved in the prevention of MTCT can help reduce the risk of transmission.\n9. **Prenatal Care**: Regular prenatal care can help identify HIV-positive women and provide them with the necessary interventions to prevent MTCT.\n10. **Healthcare Provider Education**: Healthcare providers should be educated on the latest guidelines and best practices for preventing MTCT, including the use of ART and PEP.\n\nBy implementing these strategies, the risk of perinatal transmission of HIV can be significantly reduced, and the number of children born with HIV can be decreased.",
    "true_answer": "To prevent perinatal transmission of HIV, pregnant women should take antiretroviral therapy (ART) throughout pregnancy and childbirth. ART throughout pregnancy and childbirth reduces the chances of perinatal transmission of HIV to less than 1%."
  },
  {
    "question": "What are the main cell types infected with HIV?",
    "answer": "The main cell types infected with HIV (Human Immunodeficiency Virus) are:\n\n1. **CD4+ T cells** (also known as T helper cells): These cells play a crucial role in the immune system, helping to coordinate the response to infections. HIV binds to the CD4 receptor on the surface of these cells, allowing the virus to enter and infect them.\n2. **Macrophages**: These cells are a type of white blood cell that engulf and digest foreign particles and microorganisms. Macrophages can also be infected with HIV, which can lead to the production of viral particles and the spread of the infection.\n3. **Dendritic cells**: These cells are antigen-presenting cells that help to activate T cells and initiate an immune response. Dendritic cells can also be infected with HIV, which can facilitate the spread of the virus to other cells.\n\nThese cell types are the primary targets of HIV infection, and the virus's ability to infect and destroy them is a key factor in the progression of HIV disease and the development of AIDS (Acquired Immune Deficiency Syndrome).\n\nIt's worth noting that HIV can also infect other cell types, such as:\n\n* **Lymphocytes** (B cells and natural killer cells)\n* **Monocytes** (a type of white blood cell that matures into macrophages)\n* **Microglial cells** (a type of glial cell in the central nervous system)\n\nHowever, CD4+ T cells, macrophages, and dendritic cells are the primary cell types infected with HIV and are the most important targets for antiretroviral therapy and HIV research.",
    "true_answer": "The main cell types found to be infected with HIV are CD4+ T lymphocytes and macrophage-lineage cells."
  },
  {
    "question": "What is the difference between HIV and AIDS?",
    "answer": "HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are two related but distinct medical conditions.\n\n**HIV (Human Immunodeficiency Virus):**\n\nHIV is a viral infection that attacks the body's immune system, specifically the CD4 cells (T cells), which help the immune system fight off infections. When HIV infects these cells, it can cause them to become damaged or destroyed, weakening the immune system.\n\nHIV is a chronic and manageable condition, and with proper treatment, people living with HIV can lead long and healthy lives. HIV is typically spread through:\n\n1. Unprotected sex with an infected person\n2. Sharing needles or syringes with an infected person\n3. Mother-to-child transmission during pregnancy, childbirth, or breastfeeding\n4. Blood transfusions (rarely, as blood donations are screened for HIV)\n\n**AIDS (Acquired Immune Deficiency Syndrome):**\n\nAIDS is the most advanced stage of HIV infection, where the virus has severely damaged the immune system, making the person more susceptible to opportunistic infections and certain types of cancer. AIDS is characterized by:\n\n1. A severely weakened immune system (CD4 cell count below 200 cells per cubic millimeter of blood)\n2. Presence of one or more opportunistic infections, such as pneumonia, tuberculosis, or toxoplasmosis\n3. Increased risk of certain types of cancer, such as Kaposi's sarcoma or lymphoma\n\nAIDS is a life-threatening condition that can be prevented or delayed with antiretroviral therapy (ART), which is the treatment for HIV. If left untreated, HIV can progress to AIDS, but with proper treatment, people living with HIV can prevent the progression to AIDS.\n\n**Key differences:**\n\n1. **HIV is a virus**, while **AIDS is a syndrome** (a set of symptoms and conditions) that occurs when the immune system is severely damaged by the HIV virus.\n2. **HIV is a manageable condition**, while **AIDS is a life-threatening condition** that requires immediate medical attention.\n3. **HIV can be treated**, while **AIDS is a preventable condition** that can be avoided with proper treatment and management of HIV.\n\nIn summary, HIV is a viral infection that can lead to AIDS, a more severe and life-threatening condition, if left untreated or not properly managed. Early detection, treatment, and prevention are crucial in managing HIV and preventing the progression to AIDS.",
    "true_answer": "HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. AIDS stands for acquired immunodeficiency syndrome, the most advanced stage of HIV infection."
  },
  {
    "question": "How is HIV not transmitted?",
    "answer": "HIV (Human Immunodeficiency Virus) is not transmitted through the following means:\n\n1. **Casual contact**: Shaking hands, hugging, or casual kissing with someone who has HIV does not transmit the virus.\n2. **Air or water**: HIV is not airborne, and it cannot be transmitted through breathing, coughing, or sneezing. It is also not transmitted through contaminated water or food.\n3. **Insect bites**: Mosquitoes, ticks, and other insects do not transmit HIV.\n4. **Toilet seats or public facilities**: HIV cannot survive outside the human body for long periods, so it is not transmitted through contact with toilet seats, doorknobs, or other public facilities.\n5. **Saliva, sweat, or tears**: HIV is not transmitted through contact with saliva, sweat, or tears, unless these fluids are mixed with blood or other bodily fluids that contain the virus.\n6. **Sharing food or drinks**: Sharing food, drinks, or utensils with someone who has HIV does not transmit the virus.\n7. **Coughing or sneezing**: HIV is not transmitted through coughing or sneezing, even if the person with HIV has a cough or cold.\n8. **Touching or handling**: Touching or handling objects that have come into contact with someone who has HIV, such as a keyboard or mouse, does not transmit the virus.\n9. **Donating blood**: In the United States and many other countries, blood donations are screened for HIV, and the risk of transmitting HIV through blood transfusion is extremely low.\n10. **Vaccinations**: HIV is not transmitted through vaccinations or other medical procedures that involve injections or blood draws, as long as proper sterilization and safety protocols are followed.\n\nIt's essential to remember that HIV is primarily transmitted through:\n\n* Unprotected sex with an infected person\n* Sharing needles or syringes with someone who has HIV\n* Mother-to-child transmission during pregnancy, childbirth, or breastfeeding (without proper treatment)\n* Blood transfusions from an infected donor (although this is extremely rare in countries with strict blood screening protocols)\n\nIf you have concerns about HIV transmission or want to learn more about prevention and testing, consult a healthcare professional or a trusted resource, such as the Centers for Disease Control and Prevention (CDC) or the World Health Organization (WHO).",
    "true_answer": "You cannot get HIV from: Air or water. Saliva, tears, sweat, feces, or urine that is not mixed with the blood of a person with HIV. Casual contact with a person who has HIV, such as a handshake, a hug, or a closed-mouth kiss. Contact with objects, such as toilet seats, doorknobs, or dishes used by a person who has HIV. Mosquitoes, ticks, or other biting insects. Other sexual activities that do not involve the exchange of body fluids (for example, touching). HIV can\u2019t be passed through healthy, unbroken skin."
  },
  {
    "question": "What is known about the switch that occurs between patients with latent HIV and active infection?",
    "answer": "The switch from latent HIV infection to active infection is a complex and not fully understood process, but research has provided some insights. Latent HIV infection refers to a state where the virus is present in the body, but it is not actively replicating. This state is characterized by the presence of HIV proviral DNA in infected cells, but little to no viral RNA or protein production.\n\nSeveral factors are thought to contribute to the switch from latent to active HIV infection:\n\n1. **Cellular activation**: Latent HIV-infected cells can be reactivated when they receive activation signals, such as those from cytokines, chemokines, or antigen presentation. This activation can lead to the expression of viral genes and the production of new viral particles.\n2. **Epigenetic changes**: Epigenetic modifications, such as histone acetylation and DNA methylation, play a crucial role in regulating HIV gene expression. Changes in these modifications can reactivate latent HIV by making the viral genome more accessible to transcription factors.\n3. **Transcriptional regulation**: The HIV long terminal repeat (LTR) region is a critical regulatory element that controls viral gene expression. Transcription factors, such as NF-\u03baB and Sp1, can bind to the LTR and induce viral transcription, leading to the activation of latent HIV.\n4. **Immune activation**: Chronic immune activation, which can occur in response to coinfections, inflammation, or other immune stimuli, can also contribute to the reactivation of latent HIV.\n5. **HIV-specific CD4+ T cell responses**: The presence of HIV-specific CD4+ T cells can help to maintain latency, but when these cells are depleted or dysfunctional, latent HIV can reactivate.\n6. **Viral reservoirs**: The size and composition of the viral reservoir, which consists of latently infected cells, can influence the likelihood of reactivation. Larger reservoirs and the presence of certain cell types, such as CD4+ T cells, may increase the risk of reactivation.\n7. **Host-virus interactions**: The interaction between the host immune system and the virus can also contribute to the switch from latent to active infection. For example, the presence of certain host restriction factors, such as APOBEC3G, can suppress HIV replication, while others, like Vif, can counteract these effects.\n\nThe reactivation of latent HIV is thought to occur through a series of events, including:\n\n1. **Initial reactivation**: Latent HIV-infected cells are reactivated, leading to the expression of viral genes and the production of new viral particles.\n2. **Local expansion**: The reactivated virus can infect nearby cells, leading to a local expansion of the infection.\n3. **Systemic dissemination**: The infection can then disseminate systemically, leading to a increase in viral load and the development of active HIV disease.\n\nUnderstanding the mechanisms that govern the switch from latent to active HIV infection is crucial for the development of effective strategies to cure or control HIV infection. Current research focuses on identifying the key factors that contribute to latency and reactivation, with the goal of developing therapies that can target and eliminate the latent viral reservoir.",
    "true_answer": "The switch between latent and active HIV infection is primarily driven by the activation of HIV provirus within latently infected cells. Latent HIV infection occurs when the virus integrates its genetic material into the host cell's DNA, allowing the virus to persist in a dormant state. In latent infection, viral replication and gene expression are minimal or absent, and the infected cells remain functionally normal. This form of infection is responsible for the long-term persistence of HIV in individuals, even when systemic viral replication is suppressed with antiretroviral therapy (ART). The switch to active HIV infection occurs when the provirus becomes transcriptionally active; this is often triggered by extracellular signals or events that activate the host cell . One possible mechanism for the switch involves the binding of cellular transcription factors, such as nuclear factor kappa B (NF-\u03baB) and nuclear factor of activated T-cells (NFAT), to the HIV long terminal repeat (LTR) region, resulting in the activation of proviral transcription. Other factors that can contribute to the switch include cytokines, chemokines, and cellular activation signals. This transition between latent and active HIV infection plays a critical role in the pathogenesis of the disease, as it is during periods of active infection that the virus replicates and spreads to new cells, ultimately leading to the progressive decline of the host immune system . Understanding the molecular mechanisms involved in the switch from latent to active HIV infection could help inform the development of novel therapeutic strategies aimed at targeting and eliminating latently infected cells, which represent a major obstacle to achieving a cure for HIV."
  }
]